# NovaBridge Biosciences: Form 6-K, filed Feb 6, 2026

- Company: [NovaBridge Biosciences](/companies/nbp.md) (CIK 1778016)
- Form: 6-K
- Filed: 2026-02-06
- Accepted by EDGAR: Feb 6, 2026, 08:30 ET
- Period: 2026-02-06
- Accession: 0001193125-26-040355
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1778016/000119312526040355/updated_ir_deck_-_02-06-.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1778016/000119312526040355/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1778016/000119312526040355/updated_ir_deck_-_02-06-.htm

Filed Feb 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-040355. Last ingested by Listed: Nov 2, 2026, 18:31 ET. No prices; not investment advice.